210 related articles for article (PubMed ID: 37552769)
21. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.
Ibrahim IA; Nakaya M; Kurose H
J Pharmacol Sci; 2013; 122(1):1-9. PubMed ID: 23575451
[TBL] [Abstract][Full Text] [Related]
22. G
Parichatikanond W; Duangrat R; Mangmool S
Eur J Pharmacol; 2023 Jul; 951():175780. PubMed ID: 37209939
[TBL] [Abstract][Full Text] [Related]
23. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
25. Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.
Devost D; Sleno R; Pétrin D; Zhang A; Shinjo Y; Okde R; Aoki J; Inoue A; Hébert TE
J Biol Chem; 2017 Mar; 292(13):5443-5456. PubMed ID: 28213525
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
[TBL] [Abstract][Full Text] [Related]
27. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
[TBL] [Abstract][Full Text] [Related]
28. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
29. Insights Into the Role of Angiotensin-II AT
Mathieu NM; Nakagawa P; Grobe JL; Sigmund CD
Hypertension; 2024 Jan; 81(1):6-16. PubMed ID: 37449411
[TBL] [Abstract][Full Text] [Related]
30. Identification of a β-arrestin-biased negative allosteric modulator for the β
Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535
[TBL] [Abstract][Full Text] [Related]
31. Molecular Insights into Phosphorylation-Induced Allosteric Conformational Changes in a β
Madhu MK; Debroy A; Murarka RK
J Phys Chem B; 2022 Mar; 126(9):1917-1932. PubMed ID: 35196859
[TBL] [Abstract][Full Text] [Related]
32. Quantifying biased signaling in GPCRs using BRET-based biosensors.
Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
[TBL] [Abstract][Full Text] [Related]
33. Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.
Sleno R; Devost D; Pétrin D; Zhang A; Bourque K; Shinjo Y; Aoki J; Inoue A; Hébert TE
J Biol Chem; 2017 Jul; 292(29):12139-12152. PubMed ID: 28584054
[TBL] [Abstract][Full Text] [Related]
34. Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling.
Liu CH; Gong Z; Liang ZL; Liu ZX; Yang F; Sun YJ; Ma ML; Wang YJ; Ji CR; Wang YH; Wang MJ; Cui FA; Lin A; Zheng WS; He DF; Qu CX; Xiao P; Liu CY; Thomsen AR; Joseph Cahill T; Kahsai AW; Yi F; Xiao KH; Xue T; Zhou Z; Yu X; Sun JP
Nat Commun; 2017 Feb; 8():14335. PubMed ID: 28181498
[TBL] [Abstract][Full Text] [Related]
35. Biased agonism of the angiotensin II type 1 receptor.
Godin CM; Ferguson SS
Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
[TBL] [Abstract][Full Text] [Related]
36. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
Wingler LM; Elgeti M; Hilger D; Latorraca NR; Lerch MT; Staus DP; Dror RO; Kobilka BK; Hubbell WL; Lefkowitz RJ
Cell; 2019 Jan; 176(3):468-478.e11. PubMed ID: 30639099
[TBL] [Abstract][Full Text] [Related]
38. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
Qian H; Pipolo L; Thomas WG
Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
[TBL] [Abstract][Full Text] [Related]
39. β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.
Daly C; Guseinov AA; Hahn H; Wright A; Tikhonova IG; Thomsen ARB; Plouffe B
Elife; 2023 Oct; 12():. PubMed ID: 37855711
[TBL] [Abstract][Full Text] [Related]
40. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
Fessart D; Simaan M; Laporte SA
Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
